Organoids are being used to accelerate drug discovery in various areas, including oncology and cardiovascular disease. The use of organoids, which can be derived from patients, is being explored in combination with technologies such as deep learning and automation to improve the drug development process. The potential of organoids to transform drug discovery is being supported by initiatives such as the establishment of a dedicated organoid development center, although ethical considerations are also being raised.